A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer
Clinical trial NCT01450696 · TERMINATED
Trial details
- NCT number
- NCT01450696
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-02-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.